Pfizer/Pharmacia OTC Motion Sickness Stronghold Could Make FTC Queasy

Pfizer's acquisition of Pharmacia likely will draw antitrust regulatory scrutiny to one of the combined firm's smallest product lines - OTC motion sickness tablets